Summit Therapeutics Inc. Employee-related Liabilities, Current
Summit Therapeutics Inc. (SMMT) had Employee-related Liabilities, Current of $9.44 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2026-07-23
- 2026-06-30: Employee-related Liabilities, Current $9.44M.
- 2026-03-31: Employee-related Liabilities, Current $7.07M.
- 2025-12-31: Employee-related Liabilities, Current $14.93M.
- 2025-09-30: Employee-related Liabilities, Current $10.96M.
| Period end | Employee-related Liabilities, Current |
|---|---|
| 2026-06-30 | $9.44M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $7.07M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $14.93M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $10.96M 10-Q · filed 2025-10-20 |
| 2025-06-30 | $6.59M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $4.40M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $11.98M 10-K · filed 2026-02-23 |
| 2024-09-30 | $7.96M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $4.88M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $6.03M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $5.43M 10-K · filed 2025-02-24 |
| 2023-09-30 | $3.51M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $3.53M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.42M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $5.64M 10-K · filed 2024-02-20 |
| 2022-09-30 | $2.51M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.91M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.51M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $4.13M 10-K · filed 2023-03-09 |
| 2020-12-31 | $983.00K 10-K/A · filed 2022-12-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |